Al to help heart disease diagnosis

摘要

The use of artificial intelligence to significantly improve the accuracy of coronary heart disease diagnosis has been given aboost, after its UK developer received a £10m investment.Ultromics, a spin-out from Oxford University, is developing Ai technology that analyses echocardiograms to detect signs of coronary heart disease, and is aimingto reduce diagnostic errors by up to 75 per cent.The technology, known as Topological Analysis, is already being triailed in six NHS hospitals, with 14 more due to join the trial later this year, accordingto Ross Upton. CEO and co-founder of Ultromics, alongside Paul Leeson, professor of cardiovascular medicine at Oxford University.